Katelyn Atkins, MD, PHD

@_katelynatkins presenting on risk of pulmonary artery HTN after definitive RT. Dose to the PA predicts for PAH. We need to refine treatment planning to better spare heart🫀substructures! @Dr_RayMak

Terrific job by @_katelynatkins to identifyradiation induced pulmonary🫁hypertension as a conplication of #lungcancer #radiotherapy and dosimeteic predictors of it👏👏👏 Radiationplanning is becoming really complex - and benefitting our patients‼️🙏 #lcsm #radonc #ASTRO24

@drtarsh @Dr_RayMak @jacc @ICOSociety @paulzei @carmenbergom @gwalls89 Thank you!!

@Dr_RayMak @jacc @ICOSociety @_katelynatkins @paulzei @carmenbergom @gwalls89 Congratulations on this interesting manuscript

Just out @JACC CardioOncol, we intricately map #radiation exposure from #radiotherapy for #LCSM to different sub-structures of the heart to predict the risk of 5 different classes of #cardiac arrhythmias, pointing to possibly distinct pathophys pathways. sciencedirect.com/science/articl…

@changjeesuk1 @Dr_RayMak @jacc @ICOSociety @paulzei @carmenbergom @gwalls89 Thank you so much for the kind words!! 🙏🏼

@Dr_RayMak @jacc @ICOSociety @_katelynatkins @paulzei @carmenbergom @gwalls89 Absolutely incredible work! This study is the best I’ve seen at demonstrating the connection between discrete cardiac substructure dose and distinct cardiac events. Huge congrats from Seoul! 👏

@shalinivinod13 @gwalls89 Thank you!! 🙏🏼

👏🏽👏🏽👏🏽 @_katelynatkins Cardiac Substructure RT dose assoc with arrhythmia 👉🏽PV V5 ➡️ AFib 👉🏽L circumflex V35 ➡️ A flutter 👉🏽PV V55 ➡️ SVT 👉🏽 RCA V25 ➡️Bradyarrhythmia 👉🏽 L main CA V5 ➡️ VT/asystole Read editorial @gwalls89 jacc.org/doi/full/10.10… #cardiooncology

And great editorial commentary by @gwalls89 and @Al_McWilliam jacc.org/doi/10.1016/j.… Thank you for the insightful discussion of our work and the state of the field! We are indeed “past the point of no return” for mean heart dose… @CSCancerCenter @CedarsSinai @SmidtHeart

@gwalls89 @Dr_RayMak @Al_McWilliam And thank you to @gwalls89 and @Al_McWilliam for their insightful and wise comments in their editorial !

@_katelynatkins & @Dr_RayMak take cardiac substructure-specific endpoint analysis to new heights in radiotherapy cardiotoxicity research! @Al_McWilliam & myself provide some thoughts on the implications of this awesome paper in a linked editorial: jacc.org/doi/10.1016/j.…

Informative podcast with @_katelynatkins reviewing #radiation-induced CV disease on #JACCCardioOnc #Pulse! 🔶Spectrum of RT-induced🫀diseases 🔶Overview of modern RT approaches to ⬇️ risk of🫀disease 🔶Future advances to minimize RT toxicity tinyurl.com/2bjfybue

@LisaSingerMDPhD @CedarsSinai Thanks again for inviting me!!

@CSCancerCenter @DMitra_MD @brittneychau @NiuSanford @LisaSingerMDPhD @AnnRaldow_MD @KamravaMD

Glad I’m not the only one feeling exhausted from multi-D conferences @CSCancerCenter @_katelynatkins in @JAMANetworkOpen & how factors such as parenthood, gender, time, frequency, and specialty impact #burnout from #tumorboards jamanetwork.com/journals/jaman… @TaraCohenPhD @SukiPaddaMD

Out now in @JCO_ASCO! Our work on clinical trial endpoints & inclusion criteria in GI oncology trials, and how we can better leverage RCTs to demonstrate the value of RT going forward. With @whallradonc and @TedHong9. Brief thread below. ascopubs.org/doi/abs/10.120…

Masterclass on minimising cardiotoxicity risk using cardiac substructure contours, baseline CV risk & sensible endpoints by @_katelynatkins at #ASTRO2023 Much progress in recent years but a long way still to go in lung cancer @Dr_RayMak @mctjong @carmenbergom @K_Butterworth

We are not fooled. Slow down there RAPIDO. "Short-Course Radiation Therapy and the RAPIDO Trial: Too Short, Too Soon?" @KrishanJethwa @NiuSanford redjournal.org/article/S0360-…

@HenningWillers @Dr_RayMak @OncoAlert @joe_deasy @JeffBradleyMD @CSCancerCare Great q! Resp motion not well accounted for in older scans comprising prior work (mix of mostly FB+ AIPs) - in RW, i try to ensure coronary structure accounts for motion from 4D (similar to other moving critical OARs) esp if close target proximity

@_katelynatkins @Dr_RayMak @OncoAlert @joe_deasy @JeffBradleyMD @CSCancerCare thanks!!! what do you do with resp motion? Is LAD drawn across all 4D CT phases or how do you manage this? 🙏🙏🙏

🚨Very important analysis on reducing #radiotherapy dose to LAD (V15<10%)🚨 @Dr_RayMak @_katelynatkins Can you share with us what brush size was used for contouring LAD (~7mm?) & which cc volume 10% corresponds to?🙏 @OncoAlert @joe_deasy @JeffBradleyMD redjournal.org/article/S0360-…